Hamad Medical Corporation — Doha

Public research footprint of Hamad Medical Corporation, compiled from the ClinicalTrials.gov public registry.

119

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diabetes Mellitus Type 2 · Carbapenem Resistant Bacterial Infection · Cardio Vascular Disease · Dysphagia After Stroke

Recently updated registry entries

NCT07467564 — The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With… (Recruiting)
NCT07675928 — Qatar Cardiometabolic Cohort (Not Yet Recruiting)
NCT04937660 — Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hamad Medical Corporation?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.